369 related articles for article (PubMed ID: 35541905)
1. Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury.
Xu SC; Wu W; Zhang SY
Int J Biol Sci; 2022; 18(7):2703-2713. PubMed ID: 35541905
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
Guo J; Wei X; Li Q; Li L; Yang Z; Shi Y; Qin Y; Zhang X; Wang X; Zhi X; Meng D
J Cell Physiol; 2020 Dec; 235(12):9884-9894. PubMed ID: 32510598
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
Imazio M; Klingel K; Kindermann I; Brucato A; De Rosa FG; Adler Y; De Ferrari GM
Heart; 2020 Aug; 106(15):1127-1131. PubMed ID: 32499236
[TBL] [Abstract][Full Text] [Related]
4. Wuhan 3 years after the outbreak of the pandemic-cardiological insights and perspectives.
Chen C; He W; Wang DW
Herz; 2023 Jun; 48(3):173-179. PubMed ID: 37106075
[TBL] [Abstract][Full Text] [Related]
5. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
Ozieranski K; Tyminska A; Jonik S; Marcolongo R; Baritussio A; Grabowski M; Filipiak KJ; Opolski G; Caforio ALP
J Card Fail; 2021 Jan; 27(1):92-96. PubMed ID: 33166657
[TBL] [Abstract][Full Text] [Related]
6. Covid-19 and development of heart failure: mystery and truth.
Onohuean H; Al-Kuraishy HM; Al-Gareeb AI; Qusti S; Alshammari EM; Batiha GE
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2013-2021. PubMed ID: 34480616
[TBL] [Abstract][Full Text] [Related]
7. Histologic, viral, and molecular correlates of heart disease in fatal COVID-19.
Mezache L; Nuovo GJ; Suster D; Tili E; Awad H; Radwański PB; Veeraraghavan R
Ann Diagn Pathol; 2022 Oct; 60():151983. PubMed ID: 35660807
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study.
Dal Ferro M; Bussani R; Paldino A; Nuzzi V; Collesi C; Zentilin L; Schneider E; Correa R; Silvestri F; Zacchigna S; Giacca M; Metra M; Merlo M; Sinagra G
Clin Res Cardiol; 2021 Nov; 110(11):1822-1831. PubMed ID: 34282465
[TBL] [Abstract][Full Text] [Related]
9. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
[TBL] [Abstract][Full Text] [Related]
10. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment.
Qiu H; Li J; Li J; Li H; Xin Y
Curr Cardiol Rep; 2023 Aug; 25(8):817-829. PubMed ID: 37314650
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis.
Bailey AL; Dmytrenko O; Greenberg L; Bredemeyer AL; Ma P; Liu J; Penna V; Lai L; Winkler ES; Sviben S; Brooks E; Nair AP; Heck KA; Rali AS; Simpson L; Saririan M; Hobohm D; Stump WT; Fitzpatrick JA; Xie X; Shi PY; Hinson JT; Gi WT; Schmidt C; Leuschner F; Lin CY; Diamond MS; Greenberg MJ; Lavine KJ
bioRxiv; 2020 Nov; ():. PubMed ID: 33173875
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.
Abou Hassan OK; Sheng CC; Wang TKM; Cremer PC
Curr Cardiol Rep; 2021 Aug; 23(9):129. PubMed ID: 34342728
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.
Cushion S; Arboleda V; Hasanain Y; Demory Beckler M; Hardigan P; Kesselman MM
Cureus; 2022 Apr; 14(4):e24084. PubMed ID: 35573496
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
Tomasoni D; Italia L; Adamo M; Inciardi RM; Lombardi CM; Solomon SD; Metra M
Eur J Heart Fail; 2020 Jun; 22(6):957-966. PubMed ID: 32412156
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
[TBL] [Abstract][Full Text] [Related]
18. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
19. Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
Tsai EJ; Cˇiháková D; Tucker NR
Circ Res; 2023 May; 132(10):1290-1301. PubMed ID: 37167361
[TBL] [Abstract][Full Text] [Related]
20. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
